21^st SAHF Global Virtual Conference 2020

Virtual Diabetes and MultiMorbidity, Challenges and Education in a Global Pandemic

Thursday, 15^th October 2020

Time/duration (UK Time)	Session	Presenter(s)
11:00 –11:10	Chair’s welcome (SAHF perspective)	Professor Kiran Patel
11:10 – 11:30	Diabetes “Language Matters”	Professor Partha Kar
11:30 – 11:50	Diabetes UK perspective	Mr Chris Askew
11:50 – 12:10	NHS diabetes perspective	Professor Jonathan Valabhji
12:10 – 12:30	Panel Discussion	Professor Jonathan Valabhji and Professor Partha Kar
12:30 – 12:50	Latest update on Trials Gain an up to date understanding of key recent trials in diabetes and their outcomes, including updates on diabetes and COVID-19, SGLT2 inhibitors and from recent conferences.	Dr Amar Puttanna
12:50 –13:10	20 minute Break
13:10–13:45	“Are GLP1RA the second line drug of choice for South Asians”? Symposium Sponsored by Novo Nordisk	Dr Abd Tahrani
13:45– 14:15	COVID 19: Ethnicity and Mental Health What differences are there in mental health linked to ethnicity in the UK and why? How has covid19 impacted differentially, linked to ethnicity? What practical steps can we take to bridge the disparity of health and life outcomes of those from ethnic minorities?	Dr Sridevi Kalidindi
14:15–14:45	NASH/NAFLD in relation to T2DM Burden of NASH and advanced fibrosis in patients with T2DM New methods to identify patients with advanced fibrosis New treatments being developed.	Professor Philip Newsome
14:45–15:15	Low carbohydrate diet versus low calorie diet To understand key points on nutrition composition and health To understand facts and myths about low-carb and low-calorie diets To leave with greater knowledge & less confusion than before the session	Professor Nita Forouhi
15:15– 15:45	‘Novel Insights from recent CVOTS’ To understand the pathogenesis of DKD, including Asian origin as an important risk factor, and the implications of DKD for cardiometabolic risk. To understand the recent data from the CREDENCE and Dapa-CKD trials. To understand the relevance of DKD in the management guidelines for Diabetes Mellitus, and the role of the SGLT2-Inhibitor class to improve overall cardio-renal outcomes in patients with Diabetes Mellitus.	Dr Thomas Barber
15:45 – 16:10	25 minute Break
16:10 – 16:45	“Ethnicity and COVID 19” Symposium Sponsored by Abbott	Professor Wasim Hanif
16:45 – 16:50	Introduction: Lifetime Achievement Award	Professor Wasim Hanif and Professor Kamlesh Khunti
16:50 – 17:50	Lifetime Achievement Award ‘Diabetes in South Asians: Harnessing Ancient and Modern Knowledge into Action’ Objectives: What are the dominant cause of the diabetes excess in South Asians? How has 'omics increased our understanding of causes? How do we harness this vast knowledge of diabetes causes into effective prevention strategies?	Dr Sonia Anand, Canada
17:50 – 18:00	Closing statements	Professor Kamlesh Khunti and Professor Wasim Hanif